Return of fear following extinction in youth: An event-related potential study.


Journal

Developmental psychobiology
ISSN: 1098-2302
Titre abrégé: Dev Psychobiol
Pays: United States
ID NLM: 0164074

Informations de publication

Date de publication:
11 2021
Historique:
revised: 16 07 2021
received: 01 03 2021
accepted: 19 08 2021
entrez: 21 10 2021
pubmed: 22 10 2021
medline: 26 3 2022
Statut: ppublish

Résumé

The ability to learn to differentiate safety from danger matures gradually, particularly when such learning occurs over an extended time period. And yet, most research on fear learning examines the early phases of such learning and mainly in adults. The current study examined fear conditioning and extinction, as well as one form of extended learning, return of fear (ROF). Thirty-three typically developing children (age range: 7-14 years) completed fear conditioning and extinction; self-reports and psychophysiological indices were measured at this point. Two weeks later, children completed a ROF test (n = 23), and event-related potentials (ERPs) were recorded. Results indicated successful fear acquisition and extinction. Moreover, participants reported greater fear of the conditioned stimulus (CS+) than the safety stimulus (CS-) in the ROF test 2 weeks later. In electrophysiology data, ROF manifested as a larger late positive potential (LPP) response to the CS+ than the CS-. Finally, these differences in LPP responses were positively correlated with poorer extinction, as indicated by the GSR responses 2 weeks earlier. This is the first ERP study to demonstrate ROF in children. The LPP measure may index an interplay between inhibitory and excitatory brain-related processes underlying the long-term effects of fear learning.

Identifiants

pubmed: 34674235
doi: 10.1002/dev.22189
pmc: PMC10238916
mid: NIHMS1897452
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e22189

Subventions

Organisme : Intramural NIH HHS
ID : ZIA MH002781
Pays : United States

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

J Cogn Neurosci. 2008 Jun;20(6):977-88
pubmed: 18211235
J Behav Ther Exp Psychiatry. 2021 Mar;70:101618
pubmed: 33039814
Neuropsychopharmacology. 2008 Jan;33(1):56-72
pubmed: 17882236
Depress Anxiety. 2016 Oct;33(10):917-926
pubmed: 27699940
J Child Psychol Psychiatry. 2009 Nov;50(11):1373-83
pubmed: 19754501
Soc Cogn Affect Neurosci. 2016 Sep;11(9):1411-21
pubmed: 27053767
Psychophysiology. 2011 Jun;48(6):842-51
pubmed: 21073479
Dev Sci. 2021 Jan;24(1):e13000
pubmed: 32497415
Behav Brain Res. 2021 Jun 25;408:113297
pubmed: 33862062
Am J Psychiatry. 2020 May 1;177(5):454-463
pubmed: 32252541
J Neurosci. 2010 Nov 10;30(45):14993-7
pubmed: 21068303
Depress Anxiety. 2015 Apr;32(4):277-88
pubmed: 25427438
Psychophysiology. 2018 Apr;55(4):
pubmed: 28949030
Biol Psychol. 2008 Dec;79(3):337-42
pubmed: 18822341
Behav Res Ther. 2019 May;116:131-139
pubmed: 30909082
Mol Psychiatry. 2016 Apr;21(4):500-8
pubmed: 26122585
Behav Ther. 2015 Sep;46(5):661-70
pubmed: 26459846
Brain Res. 2013 Jun 21;1516:66-75
pubmed: 23603408
Am J Psychiatry. 2013 Oct;170(10):1195-204
pubmed: 23929092
Neurosci Biobehav Rev. 2018 May;88:117-140
pubmed: 29550209
Behav Res Ther. 2019 Jan;112:42-62
pubmed: 30502721
Biol Psychiatry. 2002 Nov 15;52(10):976-86
pubmed: 12437938
J Neurosci. 2012 Oct 17;32(42):14563-72
pubmed: 23077042
Psychiatr Clin North Am. 2009 Sep;32(3):483-524
pubmed: 19716988
J Exp Child Psychol. 2016 Jun;146:95-105
pubmed: 26922673
Depress Anxiety. 2021 Mar 23;:
pubmed: 33755265
Biol Psychol. 2014 Jul;100:1-12
pubmed: 24746848
Biol Psychol. 2000 Mar;52(2):95-111
pubmed: 10699350
J Abnorm Psychol. 2009 May;118(2):311-21
pubmed: 19413406
Annu Rev Clin Psychol. 2013;9:215-48
pubmed: 23537484
Neurobiol Learn Mem. 2014 Sep;113:135-42
pubmed: 24183838
Dev Cogn Neurosci. 2012 Jan;2(1):70-80
pubmed: 22163262
Dev Psychobiol. 2012 Nov;54(7):675-84
pubmed: 22072276
Biol Psychiatry. 2007 Sep 1;62(5):446-54
pubmed: 17217927
Neurosci Biobehav Rev. 2017 Jun;77:247-285
pubmed: 28263758
Dev Cogn Neurosci. 2012 Jan;2(1):110-9
pubmed: 22163263
Electroencephalogr Clin Neurophysiol. 1983 Apr;55(4):468-84
pubmed: 6187540
Soc Cogn Affect Neurosci. 2012 Aug;7(6):611-22
pubmed: 21719425
Cogn Affect Behav Neurosci. 2006 Dec;6(4):291-7
pubmed: 17458444
Behav Res Ther. 2008 Jan;46(1):5-27
pubmed: 18005936
Soc Cogn Affect Neurosci. 2016 Apr;11(4):612-20
pubmed: 26612681

Auteurs

Shani Danon-Kraun (S)

School of Psychological Sciences and the Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel.

Omer Horovitz (O)

School of Psychological Sciences and the Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel.
Psychology Department, Tel-Hai College, Tel-Hai, Israel.

Tahl Frenkel (T)

Ziama Arkin Infancy Institute, Baruch Ivcher School of Psychology, Interdisciplinary Center (IDC), Herzliya, Israel.

Gal Richter-Levin (G)

School of Psychological Sciences and the Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel.

Daniel S Pine (DS)

Section on Development and Affective Neuroscience, National Institute of Mental Health, Bethesda, Maryland, USA.

Tomer Shechner (T)

School of Psychological Sciences and the Integrated Brain and Behavior Research Center, University of Haifa, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH